These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 6633987)

  • 1. Hepatitis B virus vaccine.
    Williams A
    Nurse Pract; 1983 Oct; 8(9):30-2. PubMed ID: 6633987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoprevention of hepatitis B in children].
    Kätzner K; Laufs R
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):124-5. PubMed ID: 6727883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination against hepatitis B virus].
    Descos B
    Pediatrie; 1990; 45(3):173-9. PubMed ID: 2160641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
    Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
    Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccines.
    Zuckerman AJ
    Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B: review of development from the discovery of the "Australia Antigen" to end of the twentieth Century.
    Yap SF
    Malays J Pathol; 2004 Jun; 26(1):1-12. PubMed ID: 16190102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [WHO spearheads global initiative to eradicate hepatitis B].
    Sylvan S
    Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral hepatitis B vaccine].
    Leone G; Melino G
    Clin Ter; 1983 Mar; 104(6):483-93. PubMed ID: 6851450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination--United States, 1982-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jun; 51(25):549-52, 563. PubMed ID: 12118536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatocellular carcinoma by immunization. A WHO meeting.
    A WHO Meeting
    Bull World Health Organ; 1983; 61(5):731-44. PubMed ID: 6317213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoprophylaxis of hepatitis B. 2. Active immunization: vaccine production, vaccine safety, side effects].
    Zoulek G; Jilg W; Deinhardt F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1175-7. PubMed ID: 6872870
    [No Abstract]   [Full Text] [Related]  

  • 16. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of children with malignant diseases with alum-absorbed hepatitis B vaccine--Immunogenicity studies.
    Arnold W; Baumann W
    Scand J Infect Dis Suppl; 1983; 38():33-6. PubMed ID: 6580724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.